Juvenile onset systemic lupus erythematosus: A possible role for vitamin D in disease status and bone health

Lupus

Volumn 21, Issue 12, 2012, Pages 1335-1342

  Casella, C B ^a   Seguro, L P C ^a   Takayama, L ^a   Medeiros, D ^a   Bonfa, E ^a   Pereira, R M R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

body composition; bone mineral density; disease activity; juvenile onset systemic lupus erythematosus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PREDNISONE; VITAMIN D;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ETHNICITY; FEMALE; HUMAN; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENARCHE; ONSET AGE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SPINE FRACTURE; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; AGE OF ONSET; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84867025697     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312454929     Document Type: Article

References (66)

1. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010 ; 9: 709-715
2. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 ; 357: 266-281
3. Giovannucci E. Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res. 2007 ; 22: V81 - V85
4. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838
5. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008 ; 37: 113-119
6. Wang S. Epidemiology of vitamin D in health and disease. Nutr Res Rev. 2009 ; 22: 188-203
7. Hyppönen E. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association?. Diabetes Obes Metab. 2010 ; 12: 737-743
8. Kivity S, Agmon-Levin Z, Zisappl M, et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011 ; 8: 243-247
9. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011 ; 35: 308-316
10. Wen H, Baker JF. Vitamin D, immunoregulation, and rheumatoid arthritis. J Clin Rheumatol. 2011 ; 17: 102-107
11. Caramaschi P, Dalla Gassa A, Ruzzenente O, et al. Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol. 2010 ; 29: 1419-1425
12. Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus. 2008 ; 17: 6-10
13. Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2009 ; 68: 446-447
14. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol. 2001 ; 28: 2535-2539
15. Cutillas-Marco E, Morales-Suárez-Varela M, Marquina-Vila A, Grant W. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus. 2010 ; 19: 810-814
16. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006 ; 5: 114-117
17. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009 ; 20: 427-433
18. Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010 ; 5: e9193 - e9193
19. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis. 2010 ; 69: 1155-1157
20. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol. 2011 ; 40: 122-126
21. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford). 2012 ; 51: 644-652
22. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus. 2011 ; 20: 1155-1160
23. Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus. 2010 ; 19: 13-19
24. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008 ; 47: 920-923
25. Souto MI, Coelho A, Guo C, Mendonça LM, Argolo S, Papi JA, et al. Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors and relationship with activity. Lupus. 2011 ; 20: 1019-1026
26. Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci. 2007 ; 1109: 385-400
27. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 ; 80: 1678S - 1688S
28. Zheng YJ, Chen S, Li ZQ, Yuan M, Ao W, Bao CD, et al. [The relationship of vitamin D endocrine system and estrogen receptor expression with bone mineral density in initial systemic lupus erythematosus]. Zhonghua Nei Ke Za Zhi. 2010 ; 49: 309-312
29. Paupitz JA, Freire de Carvalho J, Caparbo VF, Klack K, Pereira RM. Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass. Lupus. 2010 ; 19: 1302-1306
30. Pelajo CF, Lopez-Benitez JM, Miller LC. 25-Hydroxyvitamin D Levels and Vitamin D Deficiency in Children with Rheumatologic Disorders and Controls. J Rheumatol. 2011 ; 38: 2000-2004
31. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007 ; 18: 1319-1328
32. Kamen DL. Vitamin D in lupus-new kid on the block?. Bull NYU Hosp Jt Dis. 2010 ; 68: 218-222
33. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr. 2009 ; 155: 260-265
34. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
35. Fuchs SC, Guimarães SM, Sortica C, Wainberg F, Dias KO, Ughini M, et al. Reliability of race assessment based on the race of the ascendants: a cross-sectional study. BMC Public Health. 2002 ; 2: 1-5
36. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
37. Gladman D, Gingzler E, Goldsmith C, et al. Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol. 1992 ; 19: 1820-1821
38. Lopes JB, Danilevicius CF, Takayama L, Caparbo VF, Scazufca M, Bonfá E, et al. Vitamin D insufficiency: a risk factor to vertebral fractures in community-dwelling elderly women. Maturitas. 2009 ; 64: 218-222
39. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 ; 6: 1911-1930
40. Khan AA, Bachrach L, Brown JP, et al. Standards and guidelines for performing central dual-energy X-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom. 2004 ; 7: 51-64
41. Mul D, Van Suijlekom-Smit LW, Ten Cate R, Bekkering WP, De Muinck Keizer-Schrama SM. Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endocrinol Metab. 2002 ; 15: 187-192
42. Jensen MD, Kanaley JA, Roust LR, et al. Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc. 1993 ; 68: 867-873
43. Genant HK, Engelke K, Fuerst T, et al. Noninvasive Assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996 ; 11: 707-730
44. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res. 2007 ; 22: V28 - V33
45. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 ; 72: 690-693
46. Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, Netea MG, et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol. 2011 ; 164: 72-79
47. Cutolo M. Rheumatoid arthritis: circadian and circannual rhythms in RA. Nat Rev Rheumatol. 2011 ; 7: 500-502
48. Compston J. Clinical question: what is the best approach to managing glucocorticoid-induced osteoporosis?. Clin Endocrinol (Oxf). 2011 ; 74: 547-550
49. Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol. 2010 ; 6: 82-88
50. De Nijs RN. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Med. 2008 ; 99: 23-43
51. Birmingham DJ, Hebert LA, Song H, et al. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus. 2012 ; 21: 855-864
52. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001 ; 15: 2579-2585
53. Szodoray P, Nakken B, Gaal J, et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol. 2008 ; 68: 261-269
54. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine. 2010 ; 77: 552-557
55. Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev. 2011 ; 11: 84-87
56. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008 ; 4: 404-412
57. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001 ; 98: 6800-6805
58. Gauzzi MC, Purificato C, Donato K, et al. Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol. 2005 ; 174: 270-276
59. Joshi S, Pantalena LC, Liu XK, et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of IL-17A. Mol Cell Biol. 2011 ; 31: 3653-3669
60. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol. 2002 ; 2: 1017-1028
61. Geldmeyer-Hilt K, Heine G, Hartmann B, Baumgrass R, Radbruch A, Worm M. 1,25- dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells. Biochem Biophys Res Commun. 2011 ; 407: 699-702
62. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007 ; 179: 1634-1647
63. Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity. 1992 ; 12: 143-148
64. Ritterhouse LL, Crowe SR, Niewold TB, et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis. 2011 ; 70: 1569-1574
65. Luo XY, Wu LJ, Chen L, et al. [The association of vitamin D receptor gene Apal and Bsml polymorphism with systemic lupus erythematosus]. Zhonghua Nei Ke Za Zhi. 2012 ; 51: 131-135
66. Lehtonen-Veromaa MK, Möttönen TT, Nuotio IO, Irjala KM, Leino AE, Viikari JS. Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. Am J Clin Nutr. 2002 ; 76: 1446-1453